Viewing Study NCT03554005


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2025-12-26 @ 2:06 AM
Study NCT ID: NCT03554005
Status: COMPLETED
Last Update Posted: 2019-07-15
First Post: 2018-05-31
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1997-12-29
Start Date Type: ACTUAL
Primary Completion Date: 2001-03-16
Primary Completion Date Type: ACTUAL
Completion Date: 2001-03-16
Completion Date Type: ACTUAL
First Submit Date: 2018-05-31
First Submit QC Date: None
Study First Post Date: 2018-06-12
Study First Post Date Type: ACTUAL
Results First Submit Date: 2019-03-26
Results First Submit QC Date: None
Results First Post Date: 2019-07-15
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-07-12
Last Update Post Date: 2019-07-15
Last Update Post Date Type: ACTUAL